Please provide your email address to receive an email when new articles are posted on . Among pediatric patients in the Pediatric Pulmonary Hypertension Network, nearly half had group 3 disease, ...

Early diagnosis of pulmonary arterial hypertension improves five-year survival by 42%, compared with delayed diagnosis, a ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, and welcome to this InDiscussion Medscape podcast on pulmonary hypertension (PH). We're here today to talk about some ...

A study found that pulmonary hypertension often resolves within a year in premature infants with BPD, though many still ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello, and welcome to this podcast series. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular ...

Unfortunately, Epoprostenol, Tadallafil, Sotatercept, treprostinyl inhalants used for group 3 pulmonary hypertension, which are still not introduced in Korea, and Riosiguad of group 4 pulmonary ...

In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...